ArticleThe Journal of clinical investigation2026

MEK inhibitor mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy.

Aysha B Khalid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.